Showing results (21-30 of 233) with videos related to
Sort By:
Pageof 24
Thrombosis and Haemostasis|October 1, 1991
Ascorbic acid increases the thrombogenicity of cellular matricesG A Hindriks, J J Sixma, P G de GrootLupus|February 1, 1996
Primary antiphospholipid syndrome evolving into systemic lupus erythematosusR H Derksen, F H Gmelig-Meijling, P G de GrootThrombosis and Haemostasis|February 25, 1988
Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesisP Hasselaar, R H Derksen, L Blokzijl, et al.Thrombosis and Haemostasis|April 12, 1990
Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood plateletsP Hasselaar, R H Derksen, L Blokzijl, et al.International Journal of Laboratory Hematology|March 8, 2012
Recent developments in our understanding of the antiphospholipid syndromeP G De Groot, J C M Meijers, R T UrbanusSeminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin regulation by physiological inhibitors: the role of vitronectinK T Preissner, H de Boer, H Pannekoek, et al.Blood|December 1, 1994
Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparinS Beumer, M J IJsseldijk, P G de Groot, et al.Annals of the Rheumatic Diseases|September 1, 1993
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatmentR H Derksen, P G de Groot, L Kater, et al.Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia AT Lisman, P G de Groot, T Lambert, et al.Lupus|May 29, 2012
Pathophysiology of thrombotic APS: where do we stand?P G de Groot, R T Urbanus, R H W M DerksenPageof 24